Our results support this hypothesis as we showed that a high plasma CAIX level was an independent prognostic factor significantly related to worse OS and DSS of early-stage I+II NSCLC when compared with later stage III+IV NSCLC. The gene discussed is CA9; the disease is non-small cell lung carcinoma.